RegulatoryOct 15, 2024PRU Successfully Completes FDA Re-InspectionOur facility has successfully undergone FDA re-inspection with zero observations, reaffirming our commitment to quality and compliance.
EquipmentSep 20, 2024New LC-MS/MS System Enhances Bioanalytical CapacityInstallation of the latest Shimadzu LC-MS/MS 8060 system increases our analytical capacity and sensitivity.
EventsAug 10, 2024PRU Presents at International Conference on BioequivalenceOur scientific team presented groundbreaking research on complex generics at the Dubai Pharmaceutical Conference.
FacilitiesJul 05, 2024Expansion of Clinical Trial Facilities CompletedWe have expanded our clinical trial unit adding 20 additional beds and new monitoring equipment.